期刊文献+

In Vitro Characterizations of PLLA/β-TCP Porous Matrix Materials and RMSC-PLLA-β-TCP Composite Scaffolds 被引量:3

In Vitro Characterizations of PLLA/β-TCP Porous Matrix Materials and RMSC-PLLA-β-TCP Composite Scaffolds
下载PDF
导出
摘要 To develop a novel degradable poly (L-lactic acid)/β-tricalcium phosphate (PLLA/β-TCP) bioactive materials for bone tissueengineering, β-TCP powder was produced by a new wet process. Porous scaffolds were prepared by three steps, i.e. solventcasting, compression molding and leaching stage. Factors influencing the compressive strength and the degradation behaviorof the porous scaffold, e.g. weight fraction of pore forming agent-sodium chloride (NaCl), weight ratio of PLLA: β-TCP,the particle size of β-TCP and the porosity, were discussed in details. Rat marrow stromal cells (RMSC) were incorporatedinto the composite by tissue engineering approach. Biological and osteogenesis potential of the composite scaffold weredetermined with MTT assay, alkaline phosphatase (ALP) activity and bone osteocalcin (OCN) content evaluation. Resultsshow that PLLA/β-TCP bioactive porous scaffold has good mechanical and pore structure with adjustable compressive strengthneeded for surgery. RMSCs seeding on porous PLLA/β-TCP composite behaves good seeding efficacy, biocompatibility andosteoinductive potential. Osteoprogenitor cells could well penetrate into the material matrix and begin cell proliferation andosteogenic differentiation. Osseous matrix could be formed on the surface of the composite after culturing in vitro. It isexpected that the PLLA/β-TCP porous composites are promising scaffolds for bone tissue engineering in prosthesis surgery. To develop a novel degradable poly (L-lactic acid)/β-tricalcium phosphate (PLLA/β-TCP) bioactive materials for bone tissueengineering, β-TCP powder was produced by a new wet process. Porous scaffolds were prepared by three steps, i.e. solventcasting, compression molding and leaching stage. Factors influencing the compressive strength and the degradation behaviorof the porous scaffold, e.g. weight fraction of pore forming agent-sodium chloride (NaCl), weight ratio of PLLA: β-TCP,the particle size of β-TCP and the porosity, were discussed in details. Rat marrow stromal cells (RMSC) were incorporatedinto the composite by tissue engineering approach. Biological and osteogenesis potential of the composite scaffold weredetermined with MTT assay, alkaline phosphatase (ALP) activity and bone osteocalcin (OCN) content evaluation. Resultsshow that PLLA/β-TCP bioactive porous scaffold has good mechanical and pore structure with adjustable compressive strengthneeded for surgery. RMSCs seeding on porous PLLA/β-TCP composite behaves good seeding efficacy, biocompatibility andosteoinductive potential. Osteoprogenitor cells could well penetrate into the material matrix and begin cell proliferation andosteogenic differentiation. Osseous matrix could be formed on the surface of the composite after culturing in vitro. It isexpected that the PLLA/β-TCP porous composites are promising scaffolds for bone tissue engineering in prosthesis surgery.
出处 《Journal of Materials Science & Technology》 SCIE EI CAS CSCD 2004年第3期248-252,共5页 材料科学技术(英文版)
基金 This study was financially supported by 863 Hj-Tech Research Development Program of China(2002AA326080) The Fund for Youth Teacher of Education Mlinistry of China(2002123).
关键词 β-tricalcium phosphate (β-TCP) Poly (L-lactic acid)(PLLA) Rat marrow stromal cells (RMSC) OSTEOGENESIS OSTEOINDUCTION β-tricalcium phosphate (β-TCP) Poly (L-lactic acid)(PLLA) Rat marrow stromal cells (RMSC) Osteogenesis Osteoinduction
  • 相关文献

参考文献10

  • 1[1]Dali ZHOU and Changqiong ZHENG: Biomedical Materials Research in Asia (Ⅳ), Koubushi, Kankokai, Kyoto, Japan,2000, 1, 75. 被引量:1
  • 2[2]T.Uemura, J.Dong, Y.C.Wang, H.Kojima, T.Saito, D.Iejima,M.Kikuchi, J.Tanaka and T.Tateishi: Biomaterials, 2003, 24,2277. 被引量:1
  • 3[3]P.Kasten, R.Lugnbuhl, M. van Griensven, T.Barkhausen,C.Krettek, M.Bohner and U.Bosch: Biomaterials, 2003, 24,2593. 被引量:1
  • 4[4]K.Kurashina, H.Kurita, Q.Wu, A.Ohtsuka and H.Kobayashi:Biomaterials, 2002, 23, 407. 被引量:1
  • 5[5]Rui CHEN, Huaiqing CHEN, Jun HAN, Dali ZHOU and Changqiong ZHENG: J. Biomed. Eng., 2001, 18, 177. 被引量:1
  • 6[6]J.DONG, T.Uemura, Y.Shirasaki and T.Tateishi: Biomaterials, 2002, 23, 4493. 被引量:1
  • 7[7]A.A.Ignatius, P.Augat, M.Ohnmacht, P.Pokinskyj, H.J.Kock and L.E.Claes: J. Biomed. Mater. Res., 2001, 58, 254. 被引量:1
  • 8[8]C.K.Colton: Cell Transplant., 1995, 4, 415. 被引量:1
  • 9[9]M.Fini, G.Giavaresi, N.Nicoli Aldini, P.Torricelli, R.Botter,D.Beruto and R.Giardino: Biomaterials, 2002, 23, 4523. 被引量:1
  • 10[10]T.Yoshikawa, T.Noshi, H.Mitsumo, K.Hattori, K.Ichijima and Y.Takakura: Mater. Sci. Eng., 2001, 17, 19. 被引量:1

同被引文献14

引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部